ImageneBio Inc (IMA)
IMA Stock Price Chart
Explore ImageneBio Inc interactive price chart. Choose custom timeframes to analyze IMA price movements and trends.
IMA Company Profile
Discover essential business fundamentals and corporate details for ImageneBio Inc (IMA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
27 Feb 1998
Employees
10.00
Website
https://www.inmagenebio.comCEO
Kristin Yarema
Description
ImageneBio Inc (IMA) is a biotechnology company with therapies currently undergoing human trials. The firm concentrates on creating innovative medical treatments for a variety of immune-related and inflammatory diseases. A key component of their pipeline is IMG-007, a non-depleting anti-OX40 monoclonal antibody, which is now in Phase 2b clinical studies targeting atopic dermatitis.
IMA Financial Timeline
Browse a chronological timeline of ImageneBio Inc corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 23 Jul 2026
EPS estimate is -$0.98.
Earnings released on 7 May 2026
EPS came in at -$0.95 falling short of the estimated -$0.70 by -35.71%.
Earnings released on 10 Mar 2026
EPS came in at -$0.62 surpassing the estimated -$1.45 by +57.24%.
Earnings released on 12 Nov 2025
EPS came in at -$2.91 falling short of the estimated -$1.47 by -97.96%.
Stock split effective on 28 Jul 2025
Shares were split 1 : 12 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 24 Jul 2025
EPS came in at -$0.06 surpassing the estimated -$0.14 by +57.14%.
Earnings released on 8 May 2025
EPS came in at -$0.18 surpassing the estimated -$0.21 by +14.29%.
Earnings released on 6 Mar 2025
EPS came in at -$0.18 surpassing the estimated -$0.19 by +5.26%.
Earnings released on 7 Nov 2024
EPS came in at -$0.19 surpassing the estimated -$0.27 by +29.63%.
Earnings released on 8 Aug 2024
EPS came in at -$0.27 surpassing the estimated -$0.31 by +12.90%.
Earnings released on 13 May 2024
EPS came in at -$0.28 surpassing the estimated -$0.40 by +30.00%.
Earnings released on 12 Mar 2024
EPS came in at -$0.41 matching the estimated -$0.41, while revenue for the quarter reached $659.00k , missing expectations by -79.01%.
Earnings released on 9 Nov 2023
EPS came in at -$0.40 surpassing the estimated -$0.44 by +9.09%, while revenue for the quarter reached $1.19m , missing expectations by -57.83%.
Earnings released on 10 Aug 2023
EPS came in at -$0.44 surpassing the estimated -$0.48 by +8.33%, while revenue for the quarter reached $2.00m , missing expectations by -34.94%.
Earnings released on 15 May 2023
EPS came in at -$0.39 surpassing the estimated -$0.46 by +15.22%, while revenue for the quarter reached $5.31m , beating expectations by +15.25%.
Earnings released on 14 Mar 2023
EPS came in at -$0.39 surpassing the estimated -$0.53 by +26.42%, while revenue for the quarter reached $5.45m , missing expectations by -9.47%.
Earnings released on 7 Nov 2022
EPS came in at -$0.48 surpassing the estimated -$0.50 by +4.00%, while revenue for the quarter reached $6.40m , beating expectations by +48.06%.
Earnings released on 11 Aug 2022
EPS came in at -$0.57 falling short of the estimated -$0.48 by -18.75%, while revenue for the quarter reached $382.00k , missing expectations by -90.14%.
Earnings released on 12 May 2022
EPS came in at -$0.47 falling short of the estimated -$0.42 by -11.90%, while revenue for the quarter reached $3.38m , missing expectations by -25.93%.
Earnings released on 17 Mar 2022
EPS came in at $0.07 surpassing the estimated -$0.51 by +113.73%, while revenue for the quarter reached $20.22m , beating expectations by +322.42%.
Earnings released on 10 Nov 2021
EPS came in at -$0.40 surpassing the estimated -$0.41 by +2.44%, while revenue for the quarter reached $3.75m , missing expectations by -56.61%.
Earnings released on 12 Aug 2021
EPS came in at -$0.35 falling short of the estimated -$0.32 by -9.37%, while revenue for the quarter reached $3.55m , missing expectations by -9.69%.
IMA Stock Performance
Access detailed IMA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
